Emplicure has focused on development work during the fourth quarter of 2022. During the period, the company completed an exploratory PK study with Empli03, which showed a steady profile and extended release. After the results were presented, the company announced that the development of the candidate is progressing. Emplicure also initiated a collaboration with OnDosis in the field of pain management. BioStock contacted CEO Håkan Engqvist to find out more about the last quarter.
Read the full article about Emplicure at biostock.se:
https://www.biostock.se/en/2023/03/development-in-focus-for-emplicure-after-results-in-pk-study/
Detta är ett pressmeddelande från BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
https://news.cision.com/emplicure-ab/r/biostock--development-in-focus-for-emplicure-after-results-in-pk-study,c3727049
(c) 2023 Cision. All rights reserved., source Press Releases - English